O

Option Care Health

Largest independent home infusion therapy provider

Director, Finance Business Partner

Full-TimePosted on 9/30/2026
$142.3k - $237.2k/yr
Expert
Bachelor's
Chicago, IL, USA
In Person

About the job

Requirements
  • A bachelor's degree in Finance, Accounting, Economics, Business Administration, or a related field.
  • At least 10 years of progressive experience in FP&A, finance, accounting, commercial finance, or business performance management.
  • At least 5 years supporting senior business leaders in a finance business partner capacity.
  • At least 3 years of people leadership experience.
  • Experience leading budgeting, forecasting, financial modeling, and business performance management activities.
  • Demonstrated success influencing business decisions and driving operational and financial results.
  • Strong understanding of financial statements and key business performance drivers.
  • Advanced financial modeling, forecasting, and analytical capabilities.
  • Strong business acumen and the ability to connect operational performance to financial outcomes.
  • Excellent communication, presentation, and relationship management skills.
  • Ability to influence without direct authority and build strong cross-functional partnerships.
  • Strong project management and organizational skills.
  • Ability to synthesize complex information into actionable recommendations.
  • Ability to manage multiple priorities in a fast-paced environment.
  • Advanced proficiency in Microsoft Excel, PowerPoint, and financial planning systems.
Responsibilities
  • Serve as the primary finance advisor and business partner to the Business Unit President/General Manager and leadership team.
  • Partner with business leadership to drive profitable growth, operational performance, and achievement of strategic objectives.
  • Provide financial insights and recommendations to support pricing, growth initiatives, resource allocation, and business investments.
  • Translate business strategies and operating plans into actionable financial plans and performance metrics.
  • Influence decision-making through fact-based analysis, financial rigor, and strategic thinking.
  • Lead development of annual operating plans, quarterly forecasts, long-range planning activities, and monthly outlooks for the business unit.
  • Build and maintain financial forecasts covering revenue, gross profit, operating expenses, and profitability.
  • Partner with business leaders to identify opportunities and risks and incorporate changing assumptions into financial plans.
  • Develop scenario analyses and sensitivity models to evaluate alternative business strategies and outcomes.
  • Monitor and analyze business performance against budget, forecast, and prior-year results.
  • Deliver monthly business reviews, KPI reporting, variance analyses, and management reporting packages.
  • Identify key business drivers and provide actionable recommendations to improve performance.
  • Develop and maintain dashboards, scorecards, and performance metrics that support executive decision-making.
  • Communicate financial results, trends, risks, and opportunities to business leadership and finance leadership.
  • Develop financial models and business cases supporting investments, new program launches, pricing initiatives, contracting opportunities, and strategic growth initiatives.
  • Support evaluation of market opportunities, product and therapy performance, customer economics, and resource deployment decisions.
  • Partner with commercial analytics, market access, procurement, and operations teams to evaluate business performance and identify value creation opportunities.
  • Perform ad hoc analysis and executive-level decision support as needed.
  • Collaborate with Commercial, Operations, Procurement, Market Access, Commercial Analytics, Accounting, and Enterprise FP&A teams.
  • Ensure alignment between business strategies, operational plans, and financial objectives.
  • Support implementation and management of cross-functional initiatives and special projects.
  • Drive accountability for achievement of financial commitments across the business.
  • Manage finance team members supporting the business unit, including coaching, development, performance management, and talent development activities for direct reports.
  • Identify opportunities to improve forecasting accuracy, reporting efficiency, and business planning processes.
  • Enhance financial tools, models, reporting, and analytical capabilities to better support decision-making.
  • Establish efficient planning rhythms and governance processes with business stakeholders.
  • Promote financial discipline and data-driven decision-making across the organization.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.

Yahoo Finance
Jun 9th, 2026
Goldman Sachs initiates Option Care Health coverage with neutral rating, $22 price target

Option Care Health shares rose 3.5% after Goldman Sachs initiated coverage with a Neutral rating and a $22 price target, suggesting potential upside from the stock's recent price of $20.51. The move comes after the stock declined 33% over the previous six months. Whilst Goldman Sachs took a cautious stance, other firms including Deutsche Bank and UBS maintain Buy ratings on the stock. The company recently reported weak first-quarter 2026 results, with revenue of $1.35 billion missing forecasts despite a 1.3% year-on-year increase. Option Care Health also lowered its full-year revenue guidance to $5.73 billion, below analyst estimates. The stock is down 35.5% year-to-date and trading 43.2% below its 52-week high.

Associated Press
Jun 4th, 2026
Option Care Health appoints Robert Okunski as VP of investor relations

Option Care Health has appointed Robert Okunski as Vice President of Investor Relations, effective 26 May 2026. He will lead the company's investor relations strategy and serve as primary liaison with the investment community. Okunski brings over 20 years of investor relations experience across healthcare, technology and energy sectors. He joins from Enhabit Home Health & Hospice, where he served as Vice President of Investor Relations, and previously held senior positions at Velo3D, SunPower Corporation, Spansion and PeopleSoft. Option Care Health is the largest independent provider of home and alternate site infusion services in the US, employing over 8,000 staff including more than 5,000 clinicians across all 50 states.

Yahoo Finance
May 28th, 2026
Option Care Health posts weakest Q1 among home health stocks, shares drop 27%

Option Care Health, the largest independent provider of home infusion services in the US, reported Q1 revenues of $1.35 billion, up 1.3% year on year but missing analyst expectations by 3.3%. The company operates 177 locations across 43 states with over 4,500 clinicians. Chief executive John Rademacher acknowledged the "mixed performance" and expressed dissatisfaction with revenue growth momentum. Full-year guidance also fell short of analyst expectations. Across the senior health, home health and hospice sector, seven tracked companies reported a satisfactory Q1, with revenues beating consensus estimates by 0.9% on average. However, Option Care Health posted the weakest performance against analyst estimates despite raising full-year guidance. The stock has fallen 27.1% since reporting, currently trading at $21.59.